Immortalization of Human Neural Stem Cells with the c-Myc Mutant T58A
2008

Immortalization of Human Neural Stem Cells with the c-Myc Mutant T58A

publication 10 minutes Evidence: high

Author Information

Author(s): De Filippis Lidia, Ferrari Daniela, Rota Nodari Laura, Amati Bruno, Snyder Evan, Vescovi Angelo Luigi

Primary Institution: Università degli Studi Bicocca-Milan, Milan, Italy

Hypothesis

Can the c-myc T58A retroviral vector successfully immortalize human neural stem cells while retaining their essential properties?

Conclusion

The study successfully established a novel immortalized human neural stem cell line (T-IhNSC) that retains key characteristics of normal hNSCs and shows enhanced proliferation and differentiation capabilities.

Supporting Evidence

  • T-IhNSCs displayed enhanced self-renewal ability and proliferative capacity compared to wild type hNSCs.
  • T-IhNSCs generated a high percentage of oligodendrocytes, which is significant for potential therapeutic applications.
  • The immortalization process did not lead to tumorigenicity in the established cell line.

Takeaway

Scientists created a new type of brain cell that can grow and multiply quickly, which can help in studying brain diseases and developing treatments.

Methodology

The study involved transducing human neural stem cells with a c-myc T58A retroviral vector and comparing their characteristics with other stem cell lines.

Limitations

The study primarily focuses on a specific mutation and may not address all potential safety concerns related to immortalized cell lines.

Participant Demographics

Cells were derived from a 10.5-week gestational-age aborted Caucasian human fetus.

Digital Object Identifier (DOI)

10.1371/journal.pone.0003310

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication